A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III
Jeffrey Lipman(The University of Queensland), Joel M. Dulhunty(The University of Queensland), Therese Starr(Royal Brisbane and Women's Hospital), Laurent Billot(The George Institute for Global Health), Simon Finfer(The George Institute for Global Health), John Myburgh(UNSW Sydney), Colman Taylor(UNSW Sydney), Joshua S. Davis(John Hunter Hospital), Menino Osbert Cotta(The University of Queensland), Charudatt Shirwadkar(Blacktown & Mount Druitt Hospital), Jason A. Roberts(Université de Montpellier), Dorrilyn Rajbhandari(The University of Queensland), Sandra Peake(Queen Elizabeth Hospital), Parisa Glass(The University of Queensland), Shay McGuinness, Stephen J. Brett(Imperial College London), Serena Knowles(UNSW Sydney), Andrew Rhodes(St George's Hospital), Jan J. De Waele(Ghent University Hospital)
Cited by 46
Related Papers
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
|Clinical Microbiology Reviews|2015|5.1k